1-[(4-CHLOROPHENYL)CARBONYLMETHYL]-3-BENZYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
Compound with spectra: 1 NMR
![1-[(4-CHLOROPHENYL)CARBONYLMETHYL]-3-BENZYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE](/api/compound/42cUwCpDXGf.png?ph=true&h=300&w=458 "1-[(4-CHLOROPHENYL)CARBONYLMETHYL]-3-BENZYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE")
| SpectraBase Compound ID | 42cUwCpDXGf |
|---|---|
| InChI | InChI=1S/C22H17ClN2O4S/c23-18-12-10-17(11-13-18)21(26)15-24-20-9-5-4-8-19(20)22(27)25(30(24,28)29)14-16-6-2-1-3-7-16/h1-13H,14-15H2 |
| InChIKey | GPOGQIRNMWHTCE-UHFFFAOYSA-N |
| Mol Weight | 440.9 g/mol |
| Molecular Formula | C22H17ClN2O4S |
| Exact Mass | 440.059756 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-[(4-BROMOPHENYL)CARBONYLMETYL]-3-BENZYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
1-[(3,4-DICHLOROPHENYL)MEHYL]-3-ISOBUTYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
4-[(1-[2-(3-chloro-4-fluoroanilino)-2-oxoethyl]-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]-N-[2-(3,4-dimethoxyphenyl)ethyl]benzamide
7H-Dibenz[b,d]azepin-7-one, 5,6-dihydro-5-(p-tolylsulfonyl)-
N-[2-(3,4-dimethoxyphenyl)ethyl]-4-[(1-[2-(3-methoxyanilino)-2-oxoethyl]-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]benzamide
N-[2-(3,4-dimethoxyphenyl)ethyl]-4-[(2,4-dioxo-1-(2-oxo-2-phenylethyl)-1,4-dihydro-3(2H)-quinazolinyl)methyl]benzamide
5H-pyrazolo[4,3-c]quinoline, 5-[(3-methoxyphenyl)methyl]-8-methyl-3-phenyl-
4-[(1-[2-(3-chloroanilino)-2-oxoethyl]-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]-N-[2-(3,4-dimethoxyphenyl)ethyl]benzamide
N-[2-(3,4-dimethoxyphenyl)ethyl]-4-[(1-[2-(3-fluoroanilino)-2-oxoethyl]-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]benzamide
4-[(1-[2-(2,4-dimethoxyanilino)-2-oxoethyl]-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]-N-(2-furylmethyl)benzamide
| Title | Journal or Book | Year |
|---|---|---|
| Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. study of structural requirements for biological activity☆ | Bioorganic & Medicinal Chemistry | 2003 |